HNSP has a broad range of products including:
|
 |
|
U.S. FDA Approval
Treatment of moderate to severe dementia of the Alzheimer’s type |
 |
|
|
Thymalfasin for Injection, 1.6mg NMPA/EMA (Italy) Approval Chronic Hepititis B, immune response enhancer Influenza vaccination in immunocompromised individual |
Bivalirudin for Injection, 250 mg NMPA/U.S. FDA Approval Percutaneous Coronary Intervention (PCI) Percutaneous Trans Luminal Coronary Angioplasty (PTCA) |
|
|
|
|
Pregabalin Capsule, 75 mg, 300 mg U.S. FDA Approval Neuropathic pain associated with DPN; PHN, etc. |
Eptifibatide Injection, 20mg/10mL ANDA/NMPA Review Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention |
Product display
-
Levocarnitine for Injection -
Clindamycin Hydrochloride for Injection -
Inosine for Injection -
Famotidin for Injection -
Sodium Ferulate for Injection -
Scopolamine Butylbromide for Injection -
Ligustrazine Phosphate for Injection
